IGFBP4 Antikörper
-
- Target Alle IGFBP4 Antikörper anzeigen
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IGFBP4 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein of human IGFBP4 (NP_001543.2).
- Isotyp
- IgG
-
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 22-258) antibody
IGFBP4 Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (Middle Region) antibodyIGFBP4 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Pferd, Kaninchen, Schaf, Ziege, Meerschweinchen WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 180-229) antibodyIGFBP4 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Pferd, Kaninchen, Schaf, Ziege, Fledermaus WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 22-258) antibodyIGFBP4 Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal A3 unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 22-254) antibodyIGFBP4 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 66-92), (N-Term) antibodyIGFBP4 Reaktivität: Human, Maus, Ratte WB, FACS Wirt: Kaninchen Polyclonal RB20479 unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 22-258) antibodyIGFBP4 Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 96-124) antibodyIGFBP4 Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB20480 unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 66-92) antibodyIGFBP4 Reaktivität: Human, Maus WB, ELISA, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) (AA 96-124) antibodyIGFBP4 Reaktivität: Human, Maus WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB 1:500-1:2000 IHC 1:50-1:100 IF 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
- Andere Bezeichnung
- IGFBP4 (IGFBP4 Produkte)
- Synonyme
- IGFBP4 antikoerper, igfbp4 antikoerper, BP-4 antikoerper, HT29-IGFBP antikoerper, IBP4 antikoerper, IGFBP-4 antikoerper, AI875747 antikoerper, Deb2 antikoerper, IGF-BP4 antikoerper, IBP-4 antikoerper, insulin like growth factor binding protein 4 antikoerper, insulin-like growth factor-binding protein 4 antikoerper, insulin-like growth factor binding protein 4 antikoerper, IGFBP4 antikoerper, LOC100136305 antikoerper, LOC100194498 antikoerper, igfbp4 antikoerper, Igfbp4 antikoerper
- Hintergrund
- This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma in both glycosylated and non-glycosylated forms. Binding of this protein prolongs the half-life of the IGFs and alters their interaction with cell surface receptors.
- Molekulargewicht
-
Observed_MW: 17 kDa
Calculated_MW: 17 kDa/27 kDa
- Gen-ID
- 3487
- UniProt
- P22692
- Pathways
- WNT Signalweg, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process
-
